We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Bernard Escudier

Bernard Escudier MD

Institut Gustave Roussy, Villejuif, France

Recent Contributions to PracticeUpdate:

  1. Renal Cell Carcinoma: Biomarkers and Side Effects Associated With RCC Treatments—Part 5
  2. Renal Cell Carcinoma: Second-Line Therapy for RCC—Part 4
  3. Renal Cell Carcinoma: Non-Clear Cell RCC—Part 3
  4. Renal Cell Carcinoma: Frontline Treatment—Part 2
  5. Adjuvant Treatment of RCC—Part 1
  6. How Should We Treat Brain Metastases From RCC?

Most Read This Week

Recently Updated